Effects of β3-adrenoceptor antagonist on the cardiac function and expression of endothelial nitric oxide synthase in a rat model of heart failure

Chinese Critical Care Medicine

Volumn 19, Issue 11, 2007, Pages 675-678

  Gan, Run Tao ^a   Li, Wei Min ^a   Wang, Xu ^a   Wu, Shuang ^a   Kong, Yi Hui ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Adrenoceptor antagonist; Cardiac function; Heart failure; Rat; Remodeling

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ISOPRENALINE; SODIUM CHLORIDE; BETA 3 ADRENERGIC RECEPTOR; MESSENGER RNA; PROPANOLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DATA ANALYSIS; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART RATE; HEART VENTRICLE REMODELING; HEART WEIGHT; LONG TERM CARE; LUNG WEIGHT; MALE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RANDOMIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WISTAR RAT; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEART LEFT VENTRICLE FUNCTION; METABOLISM;

ANIMALS; DISEASE MODELS, ANIMAL; HEART FAILURE; MALE; NITRIC OXIDE SYNTHASE TYPE III; PROPANOLAMINES; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-3; RNA, MESSENGER; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 36549074661     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bristow M R, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts[J]. N Engl J Med,1982,307(4):205-211.
2. Brodde O E. β-adrenoceptors in cardiac disease[J]. Pharmacol Ther,1993,60(3):405-430.
3. 3-adrenergic receptor in the failing canine myocardium[J]. Circ Res,2001,89(7):599-606.
4. Langin D, Tavernier G, Lafontan M. Regulation of beta3-adrenoceptor expression in white fat cells [J]. Fundam Clin Pharmacol,1995,9(2):97-106.
5. Kitamura T, Onishi K, Dohi K, et al. The negative inotropic effect of beta3-adrenoceptor stimulation in the beating guinea pig heart[J]. J Cardiovasc Pharmacol,2000,35(5):786-790.
6. Takimoto Y, Aoyama T, Keyamura R, et al. Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat[J]. Int J Cardiol,2000,76(2-3):135-145.
7. 3-adrenoreceptors in rat hearts[J]. Diabetes,2001,50(2):455-461.
8. Teerlink J R, Pfeffer J M, Pfeffer M A. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats[J]. Circ Res,1994,75(1):105-113.
9. 3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure [J]. Am J Physiol Heart Circ Physiol,2004,286(6):H2425-H2433.
10. 3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle [J]. J Clin Invest,1998,102(7):1377-1384.
11. 3-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility [J]. J Clin Invest,2000,106 (5):697-703.
12. Chinese source.